Grant Text & Funding Citation

Grant Text and Funding Citation Resources

Writing a grant? Need text for a resources section? Need a letter of support for a grant application? Find resources that can help with the grant application and funding process from start to finish below.

computer and writing

CTSI Facilities and Resources

Writing a grant? Need text for a resources section? You may copy and paste the text, and the text-only version may be easier to use. If you notice any text that needs to be updated or have any other questions, please contact CTSI Communications.


Letters of Support

Need a letter of support for a grant application? Fielding an inquiry from a researcher who needs a letter? We are working on a new process for CTSI and CTSA hub letters of support. Meanwhile, please route requests to UF CTSI director of operations, Mendy Dunn, and research administration manager, April Braxton.


CTSA Funding Citations

The University of Florida Clinical and Translational Science Institute and its CTSA hub partner, Florida State University, are supported in part by three Clinical and Translational Science Award (CTSA) Program grants awarded on August 15, 2015, and renewed for five years on July 2, 2019, by the National Center for Advancing Translational Sciences of the National Institutes of Health.

The UF-FSU CTSA grant numbers are UL1TR001427, KL2TR001429 and TL1TR001428. For the 2019-2024 project period, each grant year begins July 1 and ends June 30. The UL1 award covers operations of the CTSA hub outside of its KL2 junior faculty and TL1 predoctoral trainee programs.

In accordance with NIH requirements, all publications, news releases or other documents about research supported in whole or in part by the UF-FSU CTSA hub or its services must cite the appropriate NIH grant number(s) and ensure compliance with the NIH Public Access Policy (see resources below).

Below is recommended language for UF investigators based on the type of support received. Thanks for remembering to cite the CTSA and submit your publications to PubMed Central!

  • KL2 Scholars:
    Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida and Florida State University Clinical and Translational Science Awards KL2TR001429 and UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
  • TL1 Trainees:
    Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida and Florida State University Clinical and Translational Science Awards TL1TR001428 and UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
  • All other support (including TRACTS, Pilot Awards and use of the UF Clinical Research Center, REDCap and any other CTSI-supported service or facility):
    Research reported in this publication was supported by the University of Florida Clinical and Translational Science Institute, which is supported in part by the NIH National Center for Advancing Translational Sciences under award number UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Previous UF CTSA Grant Numbers

  • 2009-2011: UL1RR029890, KL2RR029888, TL1RR029889
  • 2012-Sep. 30, 2015: UL1 TR000064, KL2 TR000065, TL1 TR000066

NIH Public Access Policy

Federal law requires all published peer-reviewed manuscripts funded at least in part by the NIH to be submitted in full-text to PubMed Central. Please coordinate with your accepting journal to ensure timely processing of the manuscript by the NIH Manuscript Submission System (NIHMS). See instructions in this PDF document: Open Access Compliance Instructions. Assistance is provided by the CTSI and the Health Science Center Libraries’ liaison librarians.


Designating Indirect Cost Distributions

How the CTSI Uses IDC Distributions

The CTSI uses IDC distributions to sustain subsidized access to its many services and resources for translational researchers — resources such as the Clinical Research Center, Clinical Research Vehicle, REDCap, UF Health Integrated Data Repository, pilot grants, training programs, core laboratory facilities and services, regulatory and biostatistics support, and more.

How to Select the CTSI for IDC Distributions

If you accrued indirect costs in the past fiscal year, you should have received an email from the Office of Research directing you to indicate IDC distributions. Annually, the deadline to indicate these IDCs is June 30 via the myUFL Enterprise Analytics system. Here’s how to designate:

  1. Updates to center return distributions can be completed via a UFIRST Activity. For details regarding your current sponsored project distributions, please login using your Gatorlink at https://reporting.it.ufl.edu/. Navigate to Team Content > Sponsored Program Information > Awards > Center Return.
  2. To allocate a portion of your IDCs to the CTSI, select the following overhead account information:
    1. DEPTID:29680000
    2. Department: MD-CTSI
    3. Overhead: 00082127
    4. PS Project Title: CTR-OH

Review instructions from the UF Office of Research.

Gift Icon

additional support

Contribute to the advancement of clinical research

Generous additional support for the UF CTSI comes from the UF Office of Research and UF Health. Additional support comes from in-kind contributions from various units. Private support is welcomed.